Walgreen Co., CVS Caremark Corp. and Walmart are partnering with insurance companies on Medicare Part D prescription drug plans (PDPs). Walgreens and Walmart are partnering with Coventry Health Care Inc., while CVS has teamed with Aetna. Walmart also again has a plan with Humana.
Walgreen Co. has added two executives to its pharmacy, health and wellness division’s leadership team. Dr.
Bartell Drugs has unveiled a next-generation store concept at a renovated outlet in north Seattle.
Former CVS Caremark chief executive officer Tom Ryan has joined the private equity firm Advent International as an operating partner.
Katz Group Canada/Rexall chief development officer Warren Jeffery will retire at the end of this month.
Recognizing burgeoning demand for men’s grooming products, Procter & Gamble Co. (P&G) and a CVS/pharmacy unit here have created a prototype “Guy Aisle.
A Rite Aid Corp. flu shot event in Grand Central Terminal earlier this month helped inoculate hundreds of city residents against illness and raised money for charity.
The Academy of Managed Care Pharmacy (AMCP) has named former National Association of Chain Drug Stores executive Edith Rosato chief executive officer. She succeeds Judith Cahill, who earlier this year announced that she would be retiring after 16 years as top executive at AMCP.
The people who founded, built and served the chain drug industry in this country during its halcyon days are rapidly disappearing from the scene. During the summer death claimed Charlie Bowlus, the founder and driving force behind ECRM.
Many drug chains can take justifiable pride in their efforts to rethink the shopping experience. Walgreen Co., Rite Aid Corp.
The National Association of Chain Drug Stores has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding its draft federal upper limit (FUL) list.
Though the front end has traditionally been the province of chain drug stores, independent pharmacies are driving sales at a faster rate in six health-related categories, according to a new report from Hamacher Resource Group Inc.
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
The Senate has voted down a measure that would have enabled personal importation of prescription drugs into the United States.
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
